Thrivent Financial for Lutherans Buys 1,314,177 Shares of Tema Oncology ETF $CANC

Thrivent Financial for Lutherans boosted its stake in Tema Oncology ETF (NASDAQ:CANC) by 891.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,461,649 shares of the company’s stock after acquiring an additional 1,314,177 shares during the period. Thrivent Financial for Lutherans owned 0.37% of Tema Oncology ETF worth $50,747,000 at the end of the most recent reporting period.

Separately, Flow Traders U.S. LLC purchased a new position in Tema Oncology ETF during the third quarter valued at $630,000.

Tema Oncology ETF Trading Down 2.3%

Shares of Tema Oncology ETF stock opened at $37.09 on Friday. The business has a fifty day simple moving average of $37.22 and a two-hundred day simple moving average of $35.85. The firm has a market capitalization of $173.95 million, a P/E ratio of 20.39 and a beta of 0.74. Tema Oncology ETF has a 12 month low of $22.78 and a 12 month high of $39.95.

Tema Oncology ETF Company Profile

The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.